» Articles » PMID: 22970142

Within-subject Interlaboratory Variability of QuantiFERON-TB Gold In-tube Tests

Abstract

Background: The QuantiFERON®-TB Gold In-Tube test (QFT-GIT) is a viable alternative to the tuberculin skin test (TST) for detecting Mycobacterium tuberculosis infection. However, within-subject variability may limit test utility. To assess variability, we compared results from the same subjects when QFT-GIT enzyme-linked immunosorbent assays (ELISAs) were performed in different laboratories.

Methods: Subjects were recruited at two sites and blood was tested in three labs. Two labs used the same type of automated ELISA workstation, 8-point calibration curves, and electronic data transfer. The third lab used a different automated ELISA workstation, 4-point calibration curves, and manual data entry. Variability was assessed by interpretation agreement and comparison of interferon-γ (IFN-γ) measurements. Data for subjects with discordant interpretations or discrepancies in TB Response >0.05 IU/mL were verified or corrected, and variability was reassessed using a reconciled dataset.

Results: Ninety-seven subjects had results from three labs. Eleven (11.3%) had discordant interpretations and 72 (74.2%) had discrepancies >0.05 IU/mL using unreconciled results. After correction of manual data entry errors for 9 subjects, and exclusion of 6 subjects due to methodological errors, 7 (7.7%) subjects were discordant. Of these, 6 (85.7%) had all TB Responses within 0.25 IU/mL of the manufacturer's recommended cutoff. Non-uniform error of measurement was observed, with greater variation in higher IFN-γ measurements. Within-subject standard deviation for TB Response was as high as 0.16 IU/mL, and limits of agreement ranged from -0.46 to 0.43 IU/mL for subjects with mean TB Response within 0.25 IU/mL of the cutoff.

Conclusion: Greater interlaboratory variability was associated with manual data entry and higher IFN-γ measurements. Manual data entry should be avoided. Because variability in measuring TB Response may affect interpretation, especially near the cutoff, consideration should be given to developing a range of values near the cutoff to be interpreted as "borderline," rather than negative or positive.

Citing Articles

Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China.

Lu P, Martinez L, Xue H, Liu Q, Ding X, Pan J BMC Public Health. 2025; 25(1):778.

PMID: 40001083 PMC: 11863680. DOI: 10.1186/s12889-025-21954-7.


Quantum Dot-Based Nanosensors for In Vitro Detection of .

Nikolaev V, Lepekhina T, Alliluev A, Bidram E, Sokolov P, Nabiev I Nanomaterials (Basel). 2024; 14(19).

PMID: 39404280 PMC: 11478040. DOI: 10.3390/nano14191553.


Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa.

Ntshiqa T, Chihota V, Mansukhani R, Nhlangulela L, Velen K, Charalambous S Gates Open Res. 2023; 5:66.

PMID: 37560544 PMC: 10407057. DOI: 10.12688/gatesopenres.13191.3.


Enhancing the interferon-γ release assay through omission of nil and mitogen values.

Jung Y, Park J, Park J, Lee K, Chung W, Park J Respir Res. 2023; 24(1):179.

PMID: 37420251 PMC: 10327336. DOI: 10.1186/s12931-023-02485-4.


Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States.

Winglee K, Hill A, Belknap R, Stout J, Ayers T Clin Microbiol Infect. 2022; 28(7):1023.e1-1023.e7.

PMID: 35183749 PMC: 10065409. DOI: 10.1016/j.cmi.2022.02.020.


References
1.
Hopkins W . Measures of reliability in sports medicine and science. Sports Med. 2000; 30(1):1-15. DOI: 10.2165/00007256-200030010-00001. View

2.
Doberne D, Gaur R, Banaei N . Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol. 2011; 49(8):3061-4. PMC: 3147723. DOI: 10.1128/JCM.01136-11. View

3.
Pollock N, Kashino S, Napolitano D, Sloutsky A, Joshi S, Guillet J . Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol. 2009; 30(4):392-5. PMC: 3571094. DOI: 10.1086/596606. View

4.
Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J . Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol. 2008; 15(3):425-32. PMC: 2268272. DOI: 10.1128/CVI.00398-07. View

5.
Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie E, Reddy M . T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One. 2008; 3(3):e1850. PMC: 2266993. DOI: 10.1371/journal.pone.0001850. View